产品标题 产品货号 产品规格 厂家
Human transmembrane and coiled-coil domains 1 (TMCO1) from ORIGENE TECHNOLOGIESTP30021920 ugORIGENE TECHNOLOGIES
Human transmembrane and coiled-coil domains 2 (TMCO2) from ORIGENE TECHNOLOGIESTP31106120 ugORIGENE TECHNOLOGIES
Human transmembrane and immunoglobulin domain containing 1 (TMIGD1) from ORIGENE TECHNOLOGIESTP32376120 ugORIGENE TECHNOLOGIES
Human transmembrane and immunoglobulin domain containing 2 (TMIGD2) from ORIGENE TECHNOLOGIESTP30493820 ugORIGENE TECHNOLOGIES
Human transmembrane and immunoglobulin domain containing 2 (TMIGD2), transcript variant 1 from ORIGENE TECHNOLOGIESTP72080210 ugORIGENE TECHNOLOGIES
Human transmembrane and immunoglobulin domain containing 2 (TMIGD2), transcript variant 2. from ORIGENE TECHNOLOGIESTP32981420 ugORIGENE TECHNOLOGIES
Human transmembrane and ubiquitin-like domain containing 1 (TMUB1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30770020 ugORIGENE TECHNOLOGIES
Human transmembrane and ubiquitin-like domain containing 1 (TMUB1), transcript variant 2 from ORIGENE TECHNOLOGIESTP32717920 ugORIGENE TECHNOLOGIES
Human transmembrane and ubiquitin-like domain containing 2 (TMUB2), transcript variant 1 from ORIGENE TECHNOLOGIESTP31946220 ugORIGENE TECHNOLOGIES
Human transmembrane emp24 protein transport domain containing 6 (TMED6) from ORIGENE TECHNOLOGIESTP30502220 ugORIGENE TECHNOLOGIES
Human transmembrane emp24 protein transport domain containing 9 (TMED9) from ORIGENE TECHNOLOGIESTP30065220 ugORIGENE TECHNOLOGIES
Human transmembrane emp24 protein transport domain containing 8 (TMED8) from ORIGENE TECHNOLOGIESTP31092320 ugORIGENE TECHNOLOGIES
Human transmembrane emp24 protein transport domain containing 3 (TMED3), full length from ORIGENE TECHNOLOGIESTP76029050 ugORIGENE TECHNOLOGIES
TFB2M - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4016831 kitORIGENE TECHNOLOGIES
TFB1M - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4046431 kitORIGENE TECHNOLOGIES
Tfb2m - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5174611 kitORIGENE TECHNOLOGIES
TFB2M Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30168310 ugORIGENE TECHNOLOGIES
TFCP2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4012211 kitORIGENE TECHNOLOGIES
Tfcp2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5174621 kitORIGENE TECHNOLOGIES
TFCP2L1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4092411 kitORIGENE TECHNOLOGIES
Tfcp2l1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5174631 kitORIGENE TECHNOLOGIES
TFCP2L1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30924110 ugORIGENE TECHNOLOGIES
SCP2D1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4112691 kitORIGENE TECHNOLOGIES
Scp2d1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5153991 kitORIGENE TECHNOLOGIES
Epoxide hydrolase 2, cytoplasmic (EPHX2) from ORIGENE TECHNOLOGIESLY419612100 ugORIGENE TECHNOLOGIES
Epoxide hydrolase 4 (EPHX4) from ORIGENE TECHNOLOGIESLY406478100 ugORIGENE TECHNOLOGIES
Epoxide hydrolase 3 (EPHX3), transcript variant 1 from ORIGENE TECHNOLOGIESLY411054100 ugORIGENE TECHNOLOGIES
Epoxide hydrolase 3 (EPHX3), transcript variant 2 from ORIGENE TECHNOLOGIESLY428295100 ugORIGENE TECHNOLOGIES
Epoxide hydrolase 1, microsomal (xenobiotic) (EPHX1), transcript variant 1 from ORIGENE TECHNOLOGIESLY400042100 ugORIGENE TECHNOLOGIES
Epoxide hydrolase 1, microsomal (xenobiotic) (EPHX1), transcript variant 2 from ORIGENE TECHNOLOGIESLY427767100 ugORIGENE TECHNOLOGIES
Human Pancreas; Adenoma of pancreas, microcystic from ORIGENE TECHNOLOGIESCS6206085x5umORIGENE TECHNOLOGIES
Human Pancreas; Adenoma of pancreas, microcystic (protein lysate) from ORIGENE TECHNOLOGIESCP557391150 ugORIGENE TECHNOLOGIES
Human Pancreas; Adenoma of pancreas, microcystic (protein lysate) from ORIGENE TECHNOLOGIESCP620606150 ugORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS8033885x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS8033895x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS8033905x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119305x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119315x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119325x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119335x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119355x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119365x5umORIGENE TECHNOLOGIES
Human Pancreas; Atrophy of tissue from ORIGENE TECHNOLOGIESCS6119375x5umORIGENE TECHNOLOGIES
Human Pancreas; Carcinoma of pancreas, acinar cell from ORIGENE TECHNOLOGIESCS6291655x5umORIGENE TECHNOLOGIES
Human Pancreas; Carcinoma of pancreas, acinar cell (protein lysate) from ORIGENE TECHNOLOGIESCP629168150 ugORIGENE TECHNOLOGIES
Human Pancreas; Carcinoma of pancreas, adenosquamous from ORIGENE TECHNOLOGIESCS5464875x5umORIGENE TECHNOLOGIES
Human Pancreas-Carcinoma of pancreas, adenosquamous from ORIGENE TECHNOLOGIESCS815122n/aORIGENE TECHNOLOGIES
Human Pancreas-Carcinoma of pancreas, adenosquamous from ORIGENE TECHNOLOGIESCS815138n/aORIGENE TECHNOLOGIES
Human Pancreas; Cystadenocarcinoma of pancreas, mucinous from ORIGENE TECHNOLOGIESCS5215695x5umORIGENE TECHNOLOGIES
Human Pancreas; Cystadenoma of pancreas, mucinous from ORIGENE TECHNOLOGIESCS7027415x5umORIGENE TECHNOLOGIES
 |< < 4789 4790 4791 4792 4793 4794 4795 4796 4797 > >| 第 4789/6274 页